Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Arm, Multi-center Study Evaluating the Short-term Clinical Outcomes of Ventral Hernias Treated With OviTex Reinforced Bioscaffold.

NCT03074474 is registered in ClinicalTrials.gov with Tela Bio Inc as lead sponsor.

NCT NCT03074474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Arm, Multi-center Study Evaluating the Short-term Clinical Outcomes of Ventral Hernias Treated With OviTex Reinforced Bioscaffold.
Lead sponsor
Tela Bio Inc
Phase
Not applicable
Overall status
Completed
Start date
April 24, 2017
Completion date
August 8, 2021
Enrollment
92 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hernia, ventral